Central Proteina Financials
| CPRO Stock | IDR 50.00 0.00 0.00% |
Central |
Understanding current and past Central Proteina Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Central Proteina's financial statements are interrelated, with each one affecting the others. For example, an increase in Central Proteina's assets may result in an increase in income on the income statement.
Central Proteina Stock Summary
Central Proteina competes with Bakrie Brothers, Bakrieland Development, Darma Henwa, Bakrie Sumatera, and Energi Mega. PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people.| Foreign Associate | USA |
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000105000 |
| Business Address | Puri Matari 2 |
| Sector | Food Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.cpp.co.id |
| Phone | 62 21 5019 1788 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Central Proteina without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Central Stock, because this is throwing your money away. Analyzing the key information contained in Central Proteina's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Central Proteina Key Financial Ratios
Central Proteina's financial ratios allow both analysts and investors to convert raw data from Central Proteina's financial statements into concise, actionable information that can be used to evaluate the performance of Central Proteina over time and compare it to other companies across industries.| Return On Equity | 0.13 | |||
| Return On Asset | 0.0811 | |||
| Beta | -0.12 | |||
| Z Score | 2.2 |
Central Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Central Proteina's current stock value. Our valuation model uses many indicators to compare Central Proteina value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Central Proteina competition to find correlations between indicators driving Central Proteina's intrinsic value. More Info.Central Proteina Prima is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Central Proteina Prima is roughly 1.57 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Central Proteina's earnings, one of the primary drivers of an investment's value.Central Proteina Prima Systematic Risk
Central Proteina's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Central Proteina volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Central Proteina Prima correlated with the market. If Beta is less than 0 Central Proteina generally moves in the opposite direction as compared to the market. If Central Proteina Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Central Proteina Prima is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Central Proteina is generally in the same direction as the market. If Beta > 1 Central Proteina moves generally in the same direction as, but more than the movement of the benchmark.
Central Proteina March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Central Proteina help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Central Proteina Prima. We use our internally-developed statistical techniques to arrive at the intrinsic value of Central Proteina Prima based on widely used predictive technical indicators. In general, we focus on analyzing Central Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Central Proteina's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.82 | |||
| Information Ratio | 0.0227 | |||
| Maximum Drawdown | 31.67 | |||
| Value At Risk | (1.96) | |||
| Potential Upside | 2.0 |
Other Information on Investing in Central Stock
Central Proteina financial ratios help investors to determine whether Central Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Central with respect to the benefits of owning Central Proteina security.